METHSCOPOLAMINE BROMIDE | A040642 | BRECKENRIDGE PHARMACEUTICAL INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Kulkarni Law Firm FDA-2019-P-0537 · 4 docket documents Darshan Kulkarni, Esq. of The Kulkarni Law Firm filed this citizen petition requesting that FDA's Office of Generic Drugs ensure all active pharmaceutical ingredient and finished product manufacturers of Methscopolamine Bromide tablets consistently comply with USP standards and the 2016 FDA Guidance | Other | 2019-02-04 | Denied | Kulkarni Law Firm |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$1.50
per ea
Lowest NADAC/Unit
$0.5694
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 51991019206METHSCOPOLAMINE BROM 5 MG TAB | $1.50 | EA | Generic | — | 2026-06-17 |
| 51991019101METHSCOPOLAMINE BROM 2.5 MG TB | $0.5694 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.